| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.3 | 1e-05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.004 |